Marinomed has already achieved many milestones in its short history. The selected scientific publications and press releases provide information on the most important events to date.
April 23, 2019
Marinomed Biotech AG announces top line results of the Phase III study for Budesolv
February 28, 2019
Marinomed Biotech AG: Greenshoe option fully exercised
January 29, 2019
Marinomed sets offer price at 75 Euro per share
January 29, 2019
Marinomed announces strong investor demand and expected offer price
January 23, 2019
Marinomed resumes offer period of the IPO
November 29, 2018
Marinomed suspends offer period of the current IPO
November 16, 2018
Marinomed determines IPO timeline and terms
November 05, 2018